These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8862014)
41. Monoclonal antibodies specific for P-glycoprotein. Okochi E; Iwahashi T; Tsuruo T Leukemia; 1997 Jul; 11(7):1119-23. PubMed ID: 9205000 [TBL] [Abstract][Full Text] [Related]
42. Monoclonal antibodies to P-glycoprotein: preparation and applications to basic and clinical research. Naito M; Tsuruo T Methods Enzymol; 1998; 292():258-65. PubMed ID: 9711559 [TBL] [Abstract][Full Text] [Related]
43. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen. Davies JM; Rowley MJ; MacKay IR Immunol Cell Biol; 1999 Dec; 77(6):483-90. PubMed ID: 10571668 [TBL] [Abstract][Full Text] [Related]
45. An Anti-Human Lutheran Glycoprotein Phage Antibody Inhibits Cell Migration on Laminin-511: Epitope Mapping of the Antibody. Enomoto-Okawa Y; Maeda Y; Harashima N; Sugawara Y; Katagiri F; Hozumi K; Hui KM; Nomizu M; Ito Y; Kikkawa Y PLoS One; 2017; 12(1):e0167860. PubMed ID: 28060819 [TBL] [Abstract][Full Text] [Related]
46. Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P-glycoprotein): determination of P-glycoprotein expression in multi-drug-resistant KB and CEM cell variants. Cenciarelli C; Currier SJ; Willingham MC; Thiebaut F; Germann UA; Rutherford AV; Gottesman MM; Barca S; Tombesi M; Morrone S; Santoni A; Mariani M; Ramoni C; Dupuis ML; Cianfriglia M Int J Cancer; 1991 Feb; 47(4):533-43. PubMed ID: 1704872 [TBL] [Abstract][Full Text] [Related]
47. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients. Stringaro A; Molinari A; Calcabrini A; Arancia G; Ceddia PG; Cianfriglia M; Poloni F; Mondello F; Angiolella L; De Bernardis F; Cassone A Microb Drug Resist; 2002; 8(3):235-44. PubMed ID: 12363014 [TBL] [Abstract][Full Text] [Related]
48. Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein. Vahedi S; Lusvarghi S; Pluchino K; Shafrir Y; Durell SR; Gottesman MM; Ambudkar SV Sci Rep; 2018 Aug; 8(1):12716. PubMed ID: 30143707 [TBL] [Abstract][Full Text] [Related]
49. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group. Motté P; Alberici G; Ait-Abdellah M; Bellet D J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187 [TBL] [Abstract][Full Text] [Related]
50. Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries. Davies JM; Cai YP; Weir RC; Rowley MJ Virology; 2000 Sep; 275(1):67-76. PubMed ID: 11017788 [TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT; Bolin RA; Kelly RG Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950 [TBL] [Abstract][Full Text] [Related]
53. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
54. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064 [TBL] [Abstract][Full Text] [Related]
55. The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity. Sharom FJ Biochem Soc Trans; 1997 Aug; 25(3):1088-96. PubMed ID: 9388605 [No Abstract] [Full Text] [Related]
56. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display. Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502 [TBL] [Abstract][Full Text] [Related]
57. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry. Xu Y; Ramsland PA; Davies JM; Scealy M; Nandakumar KS; Holmdahl R; Rowley MJ Mol Immunol; 2004 Jun; 41(4):411-9. PubMed ID: 15163538 [TBL] [Abstract][Full Text] [Related]
58. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab. Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057 [TBL] [Abstract][Full Text] [Related]
59. Characterization of epitopes on human interleukin-2 using phage displayed-peptide libraries: insights into antibody-peptide interactions. Vispo NS; Araña MJ; Chinea G; Ojalvo AG; Cesareni G Hybridoma; 1999 Jun; 18(3):251-5. PubMed ID: 10475239 [TBL] [Abstract][Full Text] [Related]
60. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Mechetner EB; Roninson IB Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]